Search Results - "Figueras-Roca, Marc"

Tomographic Differences in Thin Corneas Following DMEK in Fuchs Dystrophy: A Case–Control Study.

Authors: Torras-Sanvicens, Josep Figueras-Roca, Marc Rocha-de-Losada, Carlos et al.

Source: Ophthalmology & Therapy. Jan2026, Vol. 15 Issue 1, p205-219. 15p.

Correction: Tomographic Differences in Thin Corneas Following DMEK in Fuchs Dystrophy: A Case–Control Study.

Authors: Torras-Sanvicens, Josep Figueras-Roca, Marc Rocha-de-Losada, Carlos et al.

Source: Ophthalmology & Therapy. Jan2026, Vol. 15 Issue 1, p221-221. 1p.

Corneal transplantation activity in Catalonia, Spain, from 2011 to 2018: Evolution of indications and surgical techniques.

Authors: Sabater-Cruz, Noelia Figueras-Roca, Marc Padró-Pitarch, Lydia et al.

Source: PLoS ONE. 4/8/2021, Vol. 16 Issue 4, p1-9. 9p.

Progression of Retinal Ganglion Cell and Nerve Fiber Layer Loss in Spinocerebellar Ataxia 3 Patients.

Authors: Camós-Carreras, Anna Figueras-Roca, Marc Dotti-Boada, Marina et al.

Source: Cerebellum. Aug2024, Vol. 23 Issue 4, p1348-1354. 7p.

Optimization of Diabetic Macular Edema Management in the Real World: A Model of Excellence in Retina Units: The EMUREX Initiative.

Authors: Figueras-Roca, Marc Figueroa, Marta S. Calvo, Pilar et al.

Source: Ophthalmologica. 2020, Vol. 243 Issue 5, p379-390. 12p.

Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.

Authors: Figueras-Roca, Marc Sala-Puigdollers, Anna Alforja, Socorro et al.

Source: Ocular Immunology & Inflammation. 2019, Vol. 27 Issue 8, p1203-1210. 8p.

Repeatability and reproducibility of retinal and choroidal thickness measurements in Diabetic Macular Edema using Swept-source Optical Coherence Tomography.

Authors: Sala-Puigdollers, Anna Figueras-Roca, Marc Hereu, Mireia et al.

Source: PLoS ONE. 7/26/2018, Vol. 13 Issue 7, p1-12. 12p.

Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema.

Authors: Figueras-Roca, Marc Molins, Blanca Sala-Puigdollers, Anna et al.

Source: PLoS ONE. 3/22/2017, Vol. 12 Issue 3, p1-13. 13p.

Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.

Authors: Figueras-Roca, Marc Matas, Jessica Llorens, Víctor et al.

Source: Graefe's Archive of Clinical & Experimental Ophthalmology. Sep2021, Vol. 259 Issue 9, p2695-2705. 11p.

Decellularized Aged Bruch's Membrane Confers Unique Biochemical Cues to Retinal Pigment Epithelium for In Vitro Modeling of Age‐Related Macular Degeneration.

Authors: Molins, Blanca Nabaes Jodar, Mercedes Soledad de Oliveira, Eliandre et al.

Source: Aging Cell. May2026, Vol. 25 Issue 5, p1-20. 20p.

Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age–related macular degeneration: real world data from the Fight Retinal Blindness registry.

Authors: Figueras-Roca, Marc Parrado-Carrillo, Alba Nguyen, Vuong et al.

Source: Graefe's Archive of Clinical & Experimental Ophthalmology. Jun2021, Vol. 259 Issue 6, p1463-1470. 8p.

Continuous Glucose Monitoring Before and After Simultaneous Pancreas–Kidney Transplantation: Insights from a Real-World Clinical Setting.

Authors: Amor, Antonio J. Solà, Clara Ventura-Aguiar, Pedro et al.

Source: Diabetes Therapy. Apr2026, Vol. 17 Issue 4, p617-626. 10p.

Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.

Authors: Bhandari, Sanjeeb Gabrielle, Pierre-Henry Nguyen, Vuong et al.

Source: Ophthalmology & Therapy. Apr2022, Vol. 11 Issue 2, p797-810. 14p.

Creation of a neovascular age‐related macular degeneration national database using a web‐based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.

Authors: Zarranz‐Ventura, Javier Parrado‐Carrillo, Alba Nguyen, Vuong et al.

Source: Clinical & Experimental Ophthalmology. Apr2022, Vol. 50 Issue 3, p312-324. 13p.

Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.

Authors: Zarranz-Ventura, Javier Sala-Puigdollers, Anna Velazquez-Villoria, Daniel et al.

Source: PLoS ONE. 1/4/2019, Vol. 14 Issue 01, p1-13. 13p.

Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography.

Authors: Pelegrín, Laura Morató, Montse Araújo, Olga et al.

Source: Rheumatology. Jul2023, Vol. 62 Issue 7, p2475-2482. 8p.

The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.

Authors: Martínez-Lapiscina, Elena H. Fraga-Pumar, Elena Gabilondo, Iñigo et al.

Source: BMC Research Notes. 2014, Vol. 7 Issue 1, p609-630. 22p. 1 Diagram, 2 Charts.

Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus—Report 2: Diabetic Kidney Disease.

Authors: Alé-Chilet, Aníbal Bernal-Morales, Carolina Barraso, Marina et al.

Source: Journal of Clinical Medicine. Jan2022, Vol. 11 Issue 1, p197. 1p.

Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 4: Glycated Haemoglobin.

Authors: Bernal-Morales, Carolina Alé-Chilet, Aníbal Martín-Pinardel, Ruben et al.

Source: Diagnostics (2075-4418). Sep2021, Vol. 11 Issue 9, p1537. 1p.

Altered retinal structure and function in Spinocerebellar ataxia type 3.

Authors: Toulis, Vasileios Casaroli-Marano, Ricardo Camós-Carreras, Anna et al.

Source: Neurobiology of Disease. Aug2022, Vol. 170, pN.PAG-N.PAG. 1p.